Assenagon Asset Management S.A. lessened its holdings in shares of Roivant Sciences Ltd. (NASDAQ: RO

Roivant Sciences (NASDAQ:ROIV) has outperformed the market over the past 5 years by 30.08% on an ann

Analysts downgraded UWMC, ACT, ROIV, INSM; ACT’s target fell to $44.

Janux Therapeutics (NASDAQ: JANX - Get Free Report) and Roivant Sciences (NASDAQ: ROIV - Get Free Re

On Thursday, Roivant Sciences (NASDAQ:ROIV) discussed first-quarter financial results during its ear

What happened Roivant Sciences Ltd. (NASDAQ: ROIV) said Eric Venker, its president and Immunovant CE

Roivant Sciences (NASDAQ:ROIV) has outperformed the market over the past 5 years by 27.07% on an ann

Roivant Sciences (NASDAQ: ROIV) CEO Matthew Gline outlined the company's priorities for the next 12

Roivant Sciences NASDAQ: ROIV CEO Matthew Gline outlined the company's priorities for the next 12 mo

Immunovant halts IMVT-1402 CLE trial after missing primary endpoints, driving IMVT and Roivant share

Immunovant’s proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CL

Immunovant's proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CL

Immunovant's proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CL

Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcrip

Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) Director Melissa Epperly sold 4,938 shares of

Analysts initiated coverage: Buy ratings for MNOV ($6), IBIO ($7), ROIV ($51), and PAY ($42); FHN ra

Stifel analyst Alex Thompson initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rati

LISRAYA's recent approval gives ROIV a nice commercial foundation, while additional indications coul

Roivant Sciences Ltd. (ROIV) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Roivant Sciences Ltd. (ROIV) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference

TD Cowen analyst Yaron Werber maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the

Guggenheim analyst Yatin Suneja maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises th

Roivant Sciences Ltd. (ROIV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy

Crude near $98 pushes the 10-year Treasury yield above 4.8% for the first time since 2023, hammering

Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's

Roivant Sciences Ltd. (ROIV) Discusses Top Line Results from PHocus Study of Mosliciguat in PH-ILD T

U.S. stocks fell Tuesday as health care lagged, while energy gained. ABM beat estimates; oil rose, a

Jefferies analyst Dennis Ding maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the

U.S. stocks fell Tuesday, but Roivant surged 16% on positive PH-ILD trial data. Pharvaris, Solaris,

Stock futures are mixed to start the shortened week as oil prices rise

Pulmovant, a clinical-stage biotech and Roivant (NASDAQ:ROIV) company, on Tuesday shared topline dat

Roivant announced positive Phase 2 trial results for mosliciguat, demonstrating improved walk distan

Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market s

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients wi

"PH-ILD remains one of the most challenging forms of pulmonary hypertension to treat, given the

WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pulmovant, a clinical-stage biotechnology company

BASEL, Switzerland and LONDON and NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV

BASEL, Switzerland and LONDON and NEW YORK, Sept. 06, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV

FDA approves Roivant's LISRAYA for adult dermatomyositis, offering a once-daily targeted therapy

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy

Arbutus Biopharma (ABUS) stock rises after announcing a $230M stock buyback via a modified Dutch auc

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Citigroup analyst Samantha Semenkow maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raise

Guggenheim analyst Yatin Suneja maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises th

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.34) per share which missed the analy

HC Wainwright sees over $1 billion in sales potential for Argenx's Vyvgart in IMNM despite myosi

U.S. stocks halt a three-day slide as oil tumbles 5% on revived Iran truce hopes, easing inflation f

US stocks rise with Dow gaining 1% on Wednesday. The Nasdaq and S&P 500 also saw gains. Lowe&#39